GLP-1 drugs and next-generation metabolic hormone combinations are transforming the food and health landscape. This forum is designed specifically for food companies and investors seeking a deeper scientific understanding of how these medications impact the human body—not just the gut, but every system they touch. 

While many discussions focus on market disruption or nutrient-dense foods, this event is different. 

Led by top researchers at UC Davis, it offers cutting-edge insights into the physiological effects of these drugs, sparking new directions for innovation. Join us to gain actionable intelligence for product development, investment, and the future of precision nutrition. This event is developed by IIFH, in collaboration with the UC Davis Innovation and Economic Development Office and UC Davis Health and in partnership with faculty members Drs. Bethany Cummings and Sean Adams.

Click here for the full event agenda.

This event is INVITATION ONLY. If you're interested in participating, please email Kim Fisher, IIFH director of programs: kimfisher@ucdavis.edu.